HHHsin-Yi Huang

Hsin-Yi Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hsin-Yi Huang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT ‐ ACS Emulation Using National Health Insurance Claims Data

    by Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li

    Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in an East Asian population by emulating the pivotal PRASFIT‐ACS trial using Taiwan’s National Health Insurance claims data. In this study, ACS patients were classified into reduced‐dose prasugrel or clopidogrel groups post‐PCI. We estimated the intention‐to‐treat effect of initiating reduced‐dose prasugrel vs. clopidogrel on the risk of major adverse cardiovascular events (MACE) and the per‐protocol effect of treating with reduced‐dose prasugrel on major bleeding risk using Cox proportional hazard models. A total of 4833 ACS patients were analyzed, including 977 (20.2%) who received reduced‐dose prasugrel. Reduced‐dose prasugrel showed comparable effectiveness to clopidogrel in preventing MACE (HR: 0.96, 95% CI: 0.72–1.29) and did not increase bleeding risk (HR: 0.82, 95% CI: 0.36–1.90), consistent with PRASFIT‐ACS results (HR MACE : 0.85, 95% CI: 0.62–1.16; HR Bleeding : 0.82, 95% CI: 0.39–1.73). A significant reduction in cardiovascular mortality was observed (HR: 0.51, 95% CI: 0.29–0.89), differing from PRASFIT‐ACS findings (HR: 1.21, 95% CI: 0.48–3.06). Our results suggest that reduced‐dose prasugrel was effective in preventing thrombotic events in the Taiwanese population without significantly increasing bleeding risk. These findings align with pivotal trial outcomes while highlighting the importance of race‐specific dose adjustments to optimize ACS treatment strategies. Further research is needed to evaluate whether these results are applicable to other East Asian populations.


  • Open Access

    Applying translanguaging pedagogy to scaffold non-English major juniors on writing scripts for English presentations

    by Hsin-Yi Huang, Chiung-Jung Tseng, Ming-Fen Lo

    To tackle students’ English writing problems while they are drafting scripts for presentations, in this project, we propose applying translanguaging pedagogy as well as smartly utilizing Google Translate to scaffold college juniors on writing scripts for their presentations. The participants are from three intact classes of non-English major juniors taking the required “Advanced English Expression” course, where each participant will draft their scripts in Chinese first, then translate them both on their own and through Google Translate. During the revision period, teacher’s consultation will also be offered. By referring to their Google-translated version text, the students revise their self-written English scripts to achieve what they want to express. We believe that through such curriculum planning and design, the students can learn to make good use of their mother tongue and technology, cultivate critical thinking skills, and improve their knowledge and skills in English writing. This study is based on an action research method and goes to great lengths to increase teaching quality in the long run. Three versions (self-written version, Google translated version and post-edited version) of scripts from each participant in the three intact classes will be collected and further divided into two groups according to the students’ English proficiency levels for analysis. Two online writing assessment software (VocabProfiler and Scribens) are used for quantitative analysis to compare the differences in grammar and vocabulary of the three texts. Also, three trained raters employ qualitative text analysis by closely examining any improved changes in grammar and word use from each participant’s self-written to post-edited versions of scripts. Both the quantitative and qualitative results will be triangulated with the ones from the questionnaires and interviews to gain further insights. It is hoped that this research will shed light on how translanguaging pedagogy can scaffold EFL students on their writing skills and how the students of two different proficiency levels perceive toward this practice. The results of the study can be a great reference to teachers who teach ESL/ EFL writing.

  • The effect of NSAIDs exposure on breast cancer risk in female patients with autoimmune diseases

    by Chih-Hsing Hung, Yi-Ching Lin, Yu-Han Chang, Yu-Chih Lin, Hsin-Yi Huang, Wei-Ju Yeh, Ting-Yi Wu, Ming-Feng Hou

    Both breast cancer and autoimmune diseases (ADs) are predominant in women. NSAIDs are common medications for AD. Evidence on the association between NSAIDs use and breast cancer risk is controversial. We investigated the association between NSAIDs exposure and breast cancer risk in female patients with AD. AD patients older than 18 years of age were enrolled from Taiwan Longitudinal Health Insurance Database 2005. The NSAID users were defined as AD patients who had ever taken NSAIDs for at least 3 months between 2000 and 2009. All individuals were followed from the date of first diagnosis of AD to the end of 2013 to evaluate the risk of breast cancer. We estimated the adjusted hazard ratio (HR) using Cox proportional hazard regression after adjusting for age, comorbidities and medications. A total of 12 331 NSAID users and 12 331 non-NSAID users were included in this study after 1: 1 individual matching. The NSAID users were less likely to develop breast cancer than the non-NSAID users (adjusted HR: 0.37; 95% confidence interval: 0.27–0.50; P < 0.001), even if they used NSAIDs with low cumulative defined daily doses (adjusted HR: 0.42; 95% confidence interval: 0.34–0.53; P < 0.001). The incidence of new-onset breast cancer in NSAID users was significantly decreased in users taking selective cyclooxygenase 2 inhibitors, diclofenac, ibuprofen and piroxicam. Lower cumulative hazard rates were found in the AD patients who used NSAIDs (P < 0.001). NSAID exposure is associated with a decreased risk of breast cancer in female AD patients.